Page URL:

Major gene therapy trial for cystic fibrosis given go-ahead

19 March 2012
Appeared in BioNews 649

The largest trial for a gene therapy for cystic fibrosis (CF) will begin in the UK this month. Coordinated by the UK Cystic Fibrosis Gene Therapy Consortium (GTC), 130 patients will be recruited and given working copies of the defective gene that leads to their condition.

Mutations in this gene, called CFTR, cause patients' lungs to become filled with mucus, making them vulnerable to frequent chest infections and reducing their average lifespan to 35 years. As the commonest lethal inherited disease in the UK it affects 9,000 people, and over 90,000 worldwide.

Although the genetic cause has been known since 1989, there is still no cure, as it has been difficult to develop effective gene therapies that deliver the working gene directly to the lungs. As Professor Eric Alton from Imperial College London, who coordinates the GTC, told Radio 4's Today programme, his team has spent the last decade trying to find 'tricks to slip the gene in'.

Participants in the new study will receive the treatment over the course of a year using a nebulizer – a device similar to an asthma inhaler – to inhale molecules of DNA that contain the replacement gene.

Previous GTC trials have shown that the inhalation method can successfully introduce the new gene and that its effect lasts for up to a few months. The next step is to discover whether repeated exposure leads to improved lung function, and to reductions in mucus, inflammation and infection.

'No one has ever done a gene therapy study like this in cystic fibrosis before', said Dr Deborah Gill of the Nuffield Department of Clinical Laboratory Sciences at Oxford University, one of the institutes involved in the research. 'By giving the therapy over a whole year, we will have the best chance yet of seeing an improvement in patients'.

It is hoped that the trial, made possible by a £3.1 million grant from the National Institute for Health Research and the UK Medical Research Council (MRC), will lead to successful treatments, and ultimately a cure, for CF.

Professor Alton expressed hope that the new therapy 'will achieve a step change in the treatment of cystic fibrosis that focuses on the basic defect rather than just addressing the symptoms'.

While he urged caution, telling the Today programme that the science needed to be 'built up gradually', he added that if it works the researchers could 'book their tickets to Stockholm to pick up their Nobel Prize'.

Additional lab-based studies by the GTC that look into more effective gene therapy delivery methods will also be funded by the MRC.

The GTC comprises a team of clinicians and scientists from Imperial College London, the Universities of Oxford and Edinburgh, Royal Brompton and Harefield NHS Foundation and NHS Lothian. The outcome of the phase two trial will be known in Spring 2014, and regular updates will be posted on the GTC website.

Cystic fibrosis gene therapy programme gets green light with public funding
Imperial College London (press release) |  16 March 2012
'Exciting' new cystic fibrosis therapy
BBC Radio 4 (Today) |  16 March 2012
Largest gene therapy trial for cystic fibrosis begins
Medical Xpress |  16 March 2012
6 July 2015 - by Dr Nicoletta Charolidi 
A new gene therapy technique for treating cystic fibrosis has shown potential in a new study...
30 June 2014 - by Isobel Steer 
A combination of two gene-targeting drugs significantly increases the lung function of cystic fibrosis patients, a clinical trial shows....
7 May 2013 - by Siobhan Chan 
Gene therapy will be used to treat heart failure for the first time in the UK, in clinical trials being launched by the British Heart Foundation...
5 November 2012 - by Dr Lucy Spain 
The European Medicines Agency (EMA) has approved Glybera, a gene therapy to treat a rare genetic condition, lipoprotein lipase deficiency (LPLD), for sale across Europe. Glybera is the first gene therapy to be approved for the Western market and offers the first therapeutic treatment for people with LPLD....
16 July 2012 - by Marco Narajos 
Changing Futures is a website developed by young people as a project led by Nowgen. It contains free online resources, delving into cystic fibrosis (CF) and gene therapy, aimed at teenagers and teachers....
28 March 2011 - by Alison Cranage 
For the first time, gene therapy has shown promise for people with severe Parkinson's disease. Results from a proof of concept clinical trial in the US were published in the journal Lancet Neurology...
22 November 2010 - by Dr Lux Fatimathas 
American researchers have successfully treated cystic fibrosis patients with a new drug targeting the cause of the disease. Patients carrying a common genetic mutation associated with cystic fibrosis were treated with the drug VX-770...
26 July 2009 - by Dr Rebecca Robey 
Scientists have used two new techniques to fix defects in lung cells from people with cystic fibrosis, raising hope for new treatments for the disease in the future. The first study, published in the journal Plos Biology, used a gene therapy technique to treat the cells, whilst the second study, published in the American Journal of Respiratory Cell and Molecular Biology, used a drug called miglustat....
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.